Related Experiment Video
Updated: Jul 30, 2025
07:25
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.8K
Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins
1Medical and Clinical Pharmacology, Toulouse, France.
British Journal of Clinical Pharmacology
|May 15, 2023
Summary
Simvastatin shows a higher risk of rhabdomyolysis, a serious statin side effect, compared to other statins. This risk is elevated in men, older adults, and with drug interactions.
Area of Science:
- Pharmacovigilance
- Drug Safety
- Clinical Pharmacology
Background:
- Rhabdomyolysis is a severe adverse drug reaction associated with statin use.
- Limited comparative studies exist on rhabdomyolysis risk across different statin medications.
Purpose of the Study:
- To compare the reporting risk of rhabdomyolysis among seven commonly prescribed statins.
- To identify statins with potentially higher risks of inducing rhabdomyolysis.
Main Methods:
- Utilized the World Health Organization's pharmacovigilance database, VigiBase®.
- Analyzed adult rhabdomyolysis reports linked to statins (atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, simvastatin) up to December 31, 2022.
- Calculated reporting odds ratios (ROR) with 95% confidence intervals (CI) to assess risk.
Main Results:
- Identified 10,657 reports of rhabdomyolysis associated with statin use.
- Simvastatin exhibited the highest reporting risk for rhabdomyolysis (ROR = 2.20; 95% CI: 2.11–2.29) compared to other statins.
- Increased risk observed in male patients, individuals over 74 years old, and in cases involving drug interactions.
Conclusions:
- Simvastatin presents a significantly higher reporting risk for rhabdomyolysis within the analyzed pharmacovigilance data.
- Healthcare providers should consider these comparative risks, especially in male patients, the elderly, and those on concomitant medications.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
717
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
717
01:19Pharmacovigilance
919
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
919
01:08Renal Drug Clearance: Comparison Between Renal Excretion Methods
191
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
191
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
42
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
42
01:09Hepatic Drug Clearance: Effect of Protein Binding
255
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
255
01:24Serum Studies: Renal Function Tests
25
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
25